UK Markets closed

Median Technologies SA (ALMDT.PA)

Paris - Paris Delayed price. Currency in EUR
Add to watchlist
15.52-0.36 (-2.27%)
At close: 5:35PM CET

Median Technologies SA

Les Deux Arcs B
1800 route des CrEtes
Valbonne 06560

IndustryDiagnostics & Research
Full-time employees141

Key executives

NameTitlePayExercisedYear born
Mr. Fredrik BragFounder, GM, CEO & Director498kN/AN/A
Mr. Jean-Christophe MontignyChief Financial OfficerN/AN/A1965
Marjorie KoomanVP and Head of Investor & Media RelationsN/AN/AN/A
Emmanuelle LeyguesHead of Corp. & Marketing CommunicationsN/AN/AN/A
Ms. Sophie CampagnoChief of HR & Corp. ServicesN/AN/AN/A
Mr. Ciaran Mark CooperHead of Bus. Devel., Clinical Trials Imaging - North AmericaN/AN/AN/A
Mr. Takashi HayashiManaging Director of JapanN/AN/AN/A
Bill BroderickVP and Global Head of Bus. Support & Market ServicesN/AN/AN/A
Dr. Yan LiuChief Medical OfficerN/AN/AN/A
Mr. Nicolas DanoChief Operating Officer of iCRO Bus. UnitN/AN/AN/A
Amounts are as of 31 December 2019, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.


Median Technologies SA develops and markets software products and platforms for medical image analysis in France, the United States, Canada, the United Kingdom, China, and internationally. The company offers iBiopsy (Imaging BIOmarker Phenotyping System), a phenomics imaging platform empower translational research with AI powered Biomarker identification tools and inform clinical decisions using CT scan similarity search for patient profiling services; and iSee for image analysis and management in clinical trials. It also provides imaging contract research services, such as study start up, image and clinical data management, scientific consulting, independent reviews, image data processing and site support, and study close-out for studies. Median Technologies SA has a research collaboration agreement with the University of California San Diego to conduct a study for its proprietary imaging platform iBiopsy validation. The company was founded in 2002 and is based in Valbonne, France.

Corporate governance

Median Technologies SA’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.